Star Therapeutics’ fundraise, investors punish Moderna’s stock, and more biotech news National Cancer Institute/USC Norris Comprehensive Cancer Center Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi and hello from the Scripps Research Biotech Innovation Summit here in La Jolla. Joy Jiao, head of life sciences research at OpenAI, said during her fireside: “I think it’s really only a matter of time before the models become superhuman at chemistry and biology … I really do think that’s going to happen in the next year or two and that’s what I find very exciting.” STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter. West Coast Biotech & Life Sciences Reporter Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27.
STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.